The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Therapeutic approaches to protein-misfolding diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles that Govern the Folding of Protein Chains
Anfinsen, C. B. (1973) · Science · doi:10.1126/science.181.4096.223 · Cited by 7,096
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397 · cited 1×
“Unfortunately, active immunization of patients with Alzheimer's disease using Aβ 1–42 revealed antibodies crossing the blood–brain barrier causing meningoencephalitis-like inflammation in 4% of the trial participants, presumably originating from microglial activatio”
BackgroundAmyloid fibrillogenesis: themes and variations
Rochet, J.-C., & Lansbury, P. T. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)00049-4 · Cited by 1,095
Telling, G. C., Scott, M., Mastrianni, J., Gabizon, R., Torchia, M., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (1995) · Cell · doi:10.1016/0092-8674(95)90236-8 · Cited by 857
Self-citationAmyloid fibrils from muscle myoglobin
Fändrich, M., Fletcher, M. A., & Dobson, C. M. (2001) · Nature · doi:10.1038/35065514 · Cited by 799
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
Korth, C., May, B. C. H., Cohen, F. E., & Prusiner, S. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161274798 · Cited by 673
Self-citationFan, J.-Q., Ishii, S., Asano, N., & Suzuki, Y. (1999) · Nature Medicine · doi:10.1038/4801 · Cited by 614
Alternative conformations of amyloidogenic proteins govern their behavior
Kelly, J. W. (1996) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(96)80089-3 · Cited by 593
Self-citationPartial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro
Colon, W., & Kelly, J. W. (1992) · Biochemistry · doi:10.1021/bi00151a036 · Cited by 573
Self-citationMorello, J.-P., Salahpour, A., Laperrière, A., Bernier, V., Arthus, M.-F., Lonergan, M., Petäjä-Repo, U., Angers, S., Morin, D., Bichet, D. G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8688 · Cited by 565
Prevention of Transthyretin Amyloid Disease by Changing Protein Misfolding Energetics
Hammarström, P., Wiseman, R. L., Powers, E. T., & Kelly, J. W. (2003) · Science · doi:10.1126/science.1079589 · Cited by 525
Self-citationAntibodies inhibit prion propagation and clear cell cultures of prion infectivity
Peretz, D., Williamson, R. A., Kaneko, K., Vergara, J., Leclerc, E., Schmitt-Ulms, G., Mehlhorn, I. R., Legname, G., Wormald, M. R., Rudd, P. M., et al. (2001) · Nature · doi:10.1038/35089090 · Cited by 525
Sawkar, A. R., Cheng, W.-C., Beutler, E., Wong, C.-H., Balch, W. E., & Kelly, J. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192582899 · Cited by 503
Self-citationMonoclonal antibodies inhibit prion replication and delay the development of prion disease
White, A. R., Enever, P., Tayebi, M., Mushens, R., Linehan, J., Brandner, S., Anstee, D., Collinge, J., & Hawke, S. (2003) · Nature · doi:10.1038/nature01457 · Cited by 492
Alpha1-Antitrypsin Deficiency — A Model for Conformational Diseases
Carrell, R. W., & Lomas, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra010772 · Cited by 448
Burrows, J. A. J., Willis, L. K., & Perlmutter, D. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1796 · Cited by 426
Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity
Hammarström, P., Jiang, X., Hurshman, A. R., Powers, E. T., & Kelly, J. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202495199 · Cited by 359
Self-citationPrevention of Scrapie Pathogenesis by Transgenic Expression of Anti-Prion Protein Antibodies
Heppner, F. L., Musahl, C., Arrighi, I., Klein, M. A., Rülicke, T., Oesch, B., Zinkernagel, R. M., Kalinke, U., & Aguzzi, A. (2001) · Science · doi:10.1126/science.1063093 · Cited by 346
Frustaci, A., Chimenti, C., Ricci, R., Natale, L., Russo, M. A., Pieroni, M., Eng, C. M., & Desnick, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450104 · Cited by 332
Petaja-Repo, U. E. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1628 · Cited by 262
Therapeutic strategies for human amyloid diseases
Sacchettini, J. C., & Kelly, J. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd769 · Cited by 261
Self-citationFolding of Prion Protein to Its Native α-Helical Conformation Is under Kinetic Control
Baskakov, I. V., Legname, G., Prusiner, S. B., & Cohen, F. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100180200 · Cited by 233
Self-citationA contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity
Fan, J.-Q. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00158-5 · Cited by 232
β-Secretase (BACE) as a drug target for alzheimer’s disease
Vassar, R. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00157-6 · Cited by 210
Noorwez, S. M., Kuksa, V., Imanishi, Y., Zhu, L., Filipek, S., Palczewski, K., & Kaushal, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300087200 · Cited by 202
Inhibition of fibril formation in β-amyloid peptide by a novel series of benzofurans
Howlett, D. R., PERRY, A. E., GODFREY, F., SWATTON, J. E., JENNINGS, K. H., Spitzfaden, C. E., Wadsworth, H., Wood, S. J., & Markwell, R. E. (1999) · Biochemical Journal · doi:10.1042/bj3400283 · Cited by 197
Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans.
Howlett, D. R., Perry, A. E., GODFREY, F., et al. (1999) · PubMed · Cited by 180
Ficker, E., Zhao, S., Obejero-Paz, C. A., & Brown, A. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107345200 · Cited by 180
Mechanism of rescue of common p53 cancer mutations by second‐site suppressor mutations
Nikolova, P. V., Wong, K., DeDecker, B., Henckel, J., & Fersht, A. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.370 · Cited by 152
Potent inhibition of scrapie prion replication in cultured cells by bis-acridines
May, B. C. H., Fafarman, A. T., Hong, S. B., Rogers, M., Deady, L. W., Prusiner, S. B., & Cohen, F. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2627988100 · Cited by 149
Self-citationJanovick, J. A., Goulet, M. T., Bush, E. N., Greer, J., Wettlaufer, D. G., & Conn, P. M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.048454 · Cited by 136
Kelly, J. W., & Balch, W. E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304074 · Cited by 116
Self-citationSchneider, F., Hammarström, P., & Kelly, J. W. (2001) · Protein Science · doi:10.1110/ps.8901 · Cited by 105
Self-citationγ-Secretase as a Target for Alzheimer’s Disease
Wolfe, M. S. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00004-0 · Cited by 95
Peptide Inhibitors of Beta Amyloid Aggregation
Findeis, M. A. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026024607508 · Cited by 90
White, J. T., & Kelly, J. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241406698 · Cited by 86
Self-citationSpringsteel, M. F., Galietta, L. J. V., Ma, T., et al. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00435-8 · Cited by 64
Therapeutic approaches to repair defects in ΔF508 CFTR folding and cellular targeting
Powell, K., & Zeitlin, P. L. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00148-5 · Cited by 58
Spooner, E. T., Desai, R. V., Mori, C., Leverone, J. F., & Lemere, C. A. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00464-4 · Cited by 49
γ-Secretase as a Target for Alzheimers Disease
Wolfe, M. S. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026024607535 · Cited by 28
Manipulating the Folding Pathway of ΔF508 CFTR Using Chemical Chaperones
Howard, M., & Welch, W. J. (2003) · Humana Press eBooks · doi:10.1385/1-59259-187-6:267 · Cited by 13
Nonsteroidal antiinflammatory drugs as therapeutic agents for Alzheimer's disease
Golde, T. E., Eriksen, J. L., Weggen, S., Sagi, S. A., & Koo, E. H. (2002) · Drug Development Research · doi:10.1002/ddr.10093 · Cited by 4
Cited by
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
Self-citationRevisiting the role of ABC transporters in multidrug-resistant cancer
Robey, R. W., Pluchino, K. M., Hall, M. D., Fojo, A. T., Bates, S. E., & Gottesman, M. M. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0005-8 · Cited by 1,866
ER stress and the unfolded protein response
Schröder, M., & Kaufman, R. J. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.06.056 · Cited by 1,747
Metadata
- Authors
- Cohen, F. E., & Kelly, J. W.
- Venue
- Nature
- Published
- 2003-12
- Volume
- 426
- Issue
- 6968
- Pages
- 905-909
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991103963
- Cited by
- 800
- References
- 46
- FWCI
- 15.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.